Company Profile
Updated: 17-SEP-09Accentia BioPharmaceuticals Inc.
Public Company, Headquarters Location
324 S Hyde Park Ave., Ste. 350, Tampa, FL 33606-4110, United States
(813)864-2554, (813)258-6912 fax, http://www.accentia.net
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Pharmaceuticals.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/3/2009; 2194 words; ...disclosed. o BioSante Pharmaceuticals Inc., of Lincolnshire, Ill...product. o Biovest International Inc., of Worcester, Mass., a majority-owned subsidiary of Accentia Biopharmaceuticals Inc., entered an agreement with...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 2519 words; ...efficacy of the treatment. o Accentia Biopharmaceuticals Inc., of Tampa, Fla., reported...o Biovest International Inc., of Worcester, Mass...majority-owned subsidiary of Accentia Biopharmaceuticals Inc., reported findings from...
Intercept Brings In $41M To Target FXR In Liver Disease.
BIOWORLD Today; 11/3/2009; 1295 words; ...Riverbank Capital Securities Inc. and Rodman & Renshaw LLC...In other financings news: o Accentia Biopharmaceuticals Inc., of Tampa, Fla., entered...6.59 each. Additionally, Accentia converted $3.2 million of...
Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 770 words; Accentia Biopharmaceuticals Inc., of Tampa, Fla., appointed William...board of directors. Agile Therapeutics Inc., of Princeton, N.J., named Lisa...regulatory and quality assurance. Anesiva Inc., of South San Francisco, appointed...
NMM, EXK, BVTI, UCBH Have Been Added To Naked Short Lists Today.
M2 Presswire; 10/2/2009; 1988 words; ...Florida. Biovest International, Inc. is a subsidiary of Accentia Biopharmaceuticals, Inc. On November 10, 2008, Biovest...Tampa, in joint administration with Accentia Biopharmaceuticals, Inc. There is a failure to deliver in...
Recent News Articles
- Inyx's Exaeris, Inc. and Accentia BioPharmaceuticals, Inc. Sign Co-Promotion Agreement for MD Turbo(TM).
PR Newswire - April 12, 2006 - Accentia BioPharmaceuticals, Inc. and Exaeris, Inc. Sign Co-Promotion Agreement for MD Turbo(TM).
Business Wire - April 11, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning